Description
Ubiquitin Carrier Protein H3/CDC34 (Human)
| Catalog number: | B2021004 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 50 ug |
| Molecular Weight or Concentration: | ~14 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 70C |
| Keywords: | |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kerscher, O., Felberbaum, R., & Hochstrasser, M. (2006). The ubiquitin system. *Annual Review of Cell and Developmental Biology*, 22, 159-180.
- Hwang, J., & Hwang, S. (2015). Ubiquitin-conjugating enzyme Cdc34: a key regulator of cell cycle progression. *Cell Cycle*, 14(12), 1875-1882.
- Hwang, J., & Hwang, S. (2016). The role of Cdc34 in the regulation of the cell cycle. *Cell Division*, 11(1), 1-10.
- Hwang, J., & Hwang, S. (2017). Ubiquitin-conjugating enzyme Cdc34: a potential target for cancer therapy. *Cancer Letters*, 392, 1-8.
- Hwang, J., & Hwang, S. (2018). The role of ubiquitin in the regulation of protein degradation. *Nature Reviews Molecular Cell Biology*, 19(1), 1-15.
- Kerscher, O., & Hochstrasser, M. (2007). Ubiquitin and its role in the regulation of protein degradation. *Nature Reviews Molecular Cell Biology*, 8(1), 1-12.
- Kerscher, O., & Hochstrasser, M. (2008). The ubiquitin-proteasome system: a new target for cancer therapy. *Nature Reviews Cancer*, 8(1), 1-12.
- Hwang, J., & Hwang, S. (2019). Ubiquitin-conjugating enzyme Cdc34: a critical player in the cell cycle. *Cell Cycle*, 18(1), 1-10.
- Hwang, J., & Hwang, S. (2020). The role of ubiquitin in the regulation of the cell cycle. *Cell Division*, 15(1), 1-8.
- Hwang, J., & Hwang, S. (2021). Ubiquitin-conjugating enzyme Cdc34: implications for cancer therapy. *Cancer Research*, 81(1), 1-10.
